Clinical studies recruiting near Langfang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Mobile Applet for Weight Management in Obese Heart Failure Patients
NA · Langfang People's Hospital · Heart Health Research Center · NCT06455878 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · Cancer Institute&Hospital Chinese Academy of Medical Science · Antengene Biologics Limited · NCT07327229 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che
Phase 3 · Cancer Hospital Chinese Academy pf Medical Sciences · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
NA · Cancer Hospital, Chinese Academy of Medical Sciences, Hebei · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05345860 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Hebei Petro China Central Hospital · Hoffmann-La Roche · NCT07351058 A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esopha
Phase 3 · 180 · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07487896 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · Hebei Petro China Central Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256 A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With S
Phase 1 · Shanghai Virogin Biotech Co., Ltd. · NCT07262164 Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NA · Langfang People's Hospital · Beijing Anzhen Hospital · NCT07444372 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
Phase 1/Phase 2 · Hebei Petro China Central Hospital · Nanjing Immunophage Biotech Co., Ltd · NCT06717815 An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Phase N/A · Cancer Hospital Chinese Academy of Medical Sciences. · Hoffmann-La Roche · NCT07200375 Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2 · Hebei Petro China Central Hospital · Atom Therapeutics Co., Ltd · NCT07145229 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Cancer Hospital Chinese Academy of Medical Science · Pfizer · NCT06989437 Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NA · Lang Fang Campus of Cancer Hospital, Chinese Academy of Medi · Manni Huang · NCT07684508 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · Research Site · AstraZeneca · NCT07664553 A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semag
Phase 3 · Research Site · AstraZeneca · NCT07662213 Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors
Phase 1 · Cancer Hospital Chinese Academy of Medical Scienc · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07656116 A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabet
Phase 3 · Hebei Petro China Central Hospital · Hoffmann-La Roche · NCT07670416 JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcino
Phase 3 · Cancer Hospital Chinese Academy of Medical Sciences Langfang · Shanghai Junshi Bioscience Co., Ltd. · NCT07284134 An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Ap
Phase 1 · Hebei CNPC Central Hospital · Hangzhou Yirui Pharmaceutical Technology Co., Ltd · NCT07673458 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without T
Phase 3 · Hebei Petro China Central Hospital · Hoffmann-La Roche · NCT07351045 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
Phase 2 · Hebei PetroChina Central Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07398859 A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 2 · Hebei PetroChina Central Hospital · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT07292714 Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · Investigational Site Number : 1560023 · Sanofi · NCT07190209 Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
Phase N/A · Hebei Petro China Central Hospital · Beijing Tiantan Hospital · NCT06429774 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
Phase 1/Phase 2 · Hebei Zhongshiyou Central Hospital · Sinocelltech Ltd. · NCT06754605 A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
Phase 1/Phase 2 · National Cancer Center/Cancer Hospital- Langfang Campus, Chi · Jacobio Pharmaceuticals Co., Ltd. · NCT06959615 CCTA Improves Clinical Management of Stable Chest Pain
Phase N/A · Hebei Petrochina Central Hospital · Tianjin Chest Hospital · NCT04691037

Look up another city

Look up another condition